Jim van Heusden

Président chez Breye Therapeutics ApS

Profil

Jim van Heusden founded Bioskills BVBA in 2013, where he worked as Managing Director in 2015.
Dr. van Heusden also currently works at ReWind Therapeutics NV, as Executive Chairman, Breye Therapeutics ApS, as Chairman, and FlandersBio vzw, as Director.
Dr. van Heusden also formerly worked at Karolinska Development AB (Private Equity), as CEO from 2015 to 2017, Karolinska Development AB, as Chief Executive Officer, Media & IR Contact from 2015 to 2017, Nereus Pharmaceuticals, Inc., as Director, CropDesign NV, as Director, Ablynx NV, as Non-Executive Director, MyCartis NV, as Non-Executive Director, Intrexon ActoBiotics NV, as Director, Prosensa Holding NV, as Director-Supervisory Board from 2008 to 2013, Aprea Therapeutics AB, as Director, Ovizio Imaging Systems SA, as Director, Multiplicom NV, as Director, Modus Therapeutics AB, as Director, Biogazelle NV, as Director, Gimv NV, as Partner, Gimv Life Sciences, as Partner from 2010 to 2013, and Janssen Pharmaceutica NV, as Senior Scientist.
Dr. van Heusden received his doctorate degree from Maastricht University and undergraduate degree and graduate degree from the University of Antwerp.

Postes actifs de Jim van Heusden

Sociétés	Poste	Début
FlandersBio vzw	Directeur/Membre du Conseil	-
ReWind Therapeutics NV	Président	-
Breye Therapeutics ApS	Président	-

Anciens postes connus de Jim van Heusden

Sociétés	Poste	Fin
KAROLINSKA DEVELOPMENT AB	Directeur Général	01/06/2017
Karolinska Development AB (Private Equity)	Directeur Général	31/05/2017
Bioskills BV	Directeur Général	01/01/2015
Gimv Life Sciences	Corporate Officer/Principal	01/06/2013
Nereus Pharmaceuticals, Inc.	Directeur/Membre du Conseil	29/04/2013

Formation de Jim van Heusden

Maastricht University	Doctorate Degree
University of Antwerp	Graduate Degree